Cargando…
Hinokitiol up-regulates miR-494-3p to suppress BMI1 expression and inhibits self-renewal of breast cancer stem/progenitor cells
Hinokitiol (β-thujaplicin) is a tropolone-related compound that has anti-microbe, anti-inflammation, and anti-tumor effects. Cancer stem/progenitor cells (CSCs) are a subpopulation of cancer cells with tumor initiation, chemoresistant, and metastatic properties and have been considered the important...
Autores principales: | Chen, Shih-Ming, Wang, Bing-Yen, Lee, Che-Hsin, Lee, Hsueh-Te, Li, Jung-Jung, Hong, Guan-Ci, Hung, Yu-Chieh, Chien, Peng-Ju, Chang, Che-Ying, Hsu, Li-Sung, Chang, Wen-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652685/ https://www.ncbi.nlm.nih.gov/pubmed/29100291 http://dx.doi.org/10.18632/oncotarget.18648 |
Ejemplares similares
-
Hinokitiol reduces tumor metastasis by inhibiting heparanase via extracellular signal-regulated kinase and protein kinase B pathway
por: Wu, Yueh-Jung, et al.
Publicado: (2020) -
Hinokitiol impedes tumor drug resistance by suppressing protein kinase B/mammalian targets of rapamycin axis
por: Ni, Ying-Jui, et al.
Publicado: (2022) -
Hinokitiol Inhibits Melanogenesis via AKT/mTOR Signaling in B16F10 Mouse Melanoma Cells
por: Tsao, Yu-Tzu, et al.
Publicado: (2016) -
Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2
por: Lee, Yueh-Chun, et al.
Publicado: (2017) -
New therapeutic strategy of hinokitiol in haemorrhagic shock‐induced liver injury
por: Lu, Wan‐Jung, et al.
Publicado: (2018)